Thoracic Cancer Clinical Trials

14 recruiting

Thoracic Cancer Trials at a Glance

16 actively recruiting trials for thoracic cancer are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in New York, Boston, and Beijing. Lead sponsors running thoracic cancer studies include Peking University Third Hospital, The New York Proton Center, and Varian, a Siemens Healthineers Company.

Browse thoracic cancer trials by phase

Treatments under study

About Thoracic Cancer Clinical Trials

Looking for clinical trials for Thoracic Cancer? There are currently 14 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Thoracic Cancer trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Thoracic Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 116 of 16 trials

Recruiting

Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining

Thoracic CancersLung Cancer NOSMalignant Pleural Mesotheliomas NOS+2 more
National Cancer Institute (NCI)1,559 enrolled1 locationNCT00242723
Recruiting

Variability and Post-op AEs: Does Preoperative CardioPulmonary Variability Assessment Identify Risk of Postoperative Adverse Events Following Thoracic Surgery

Thoracic CancerComplication,Postoperative
Ottawa Hospital Research Institute130 enrolled1 locationNCT07016022
Recruiting
Phase 1Phase 2

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

Lung CancerNSCLCThoracic Cancer+5 more
Tango Therapeutics, Inc.183 enrolled18 locationsNCT06922591
Recruiting

Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer

Thoracic Cancer
The New York Proton Center40 enrolled1 locationNCT06342284
Recruiting
Not Applicable

Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors

Breast CancerProstate CancerHead and Neck Cancer+4 more
The New York Proton Center1,800 enrolled1 locationNCT05313191
Recruiting

Thoracic Surgery by the Medtronic Hugo™ Robotic System

Thoracic Cancer
Chinese University of Hong Kong50 enrolled1 locationNCT06669104
Recruiting
Not Applicable

Feasibility Study of CBCT for IGRT in Cancer Patients

Breast CancerLiver CancerHead and Neck Cancers+3 more
Varian, a Siemens Healthineers Company50 enrolled4 locationsNCT06681233
Recruiting

Curatively Intended Thoracic Reirradiation

Radiotherapy Side EffectLung CancerThoracic Cancer+2 more
University of Aarhus500 enrolled1 locationNCT06950073
Recruiting

Prospective Data Collection Initiative on Thoracic Malignancies

Lung CancerThoracic CancerThymus Cancer+5 more
Dutch Society of Physicians for Pulmonology and Tuberculosis12,000 enrolled10 locationsNCT06996249
Recruiting
Phase 4

Erector Spinae Block for Thoracic Surgery

Thoracic CancerPulmonary CancerThoracic Neoplasms+2 more
George Washington University70 enrolled1 locationNCT05521789
Recruiting
Not Applicable

SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention)

Thoracic CancerGastrointestinal CancerHematologic Cancer
Nadine McCleary, MD, MPH210 enrolled3 locationsNCT05375643
Recruiting
Not Applicable

A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer

Ovarian CancerMelanomaHead and Neck Cancer+5 more
Memorial Sloan Kettering Cancer Center480 enrolled7 locationsNCT05053230
Recruiting

Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT

Head and Neck CancerCancerGynecologic Cancer+2 more
University of California, San Francisco125 enrolled1 locationNCT06633224
Recruiting
Not Applicable

Evaluation of On-Couch CBCT Image Quality

Head and Neck CancerThoracic CancerAbdominal Cancer+1 more
Varian, a Siemens Healthineers Company46 enrolled1 locationNCT06576908
Recruiting

Safety and Efficacy of SBRT in the Treatment of Thoracic Malignant Tumors at Different Sites

Thoracic CancerRadiotherapySafety and Efficacy
Peking University Third Hospital120 enrolled1 locationNCT05349552
Recruiting
Not Applicable

3DPCT Combined With CT Guided RISI in the Treatment of Thoracic Malignant Tumors

Thoracic CancerRadioactive Iodine-125 Brachytherapy3D Printing Coplanar Template+1 more
Peking University Third Hospital30 enrolled1 locationNCT05351268